Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Big Picture Bio has launched with £2.2 million in funding [...]

Oncodesign Services and Nexus BioQuest have formed a preclinical research [...]

The FDA has cleared Sapience Therapeutics to begin clinical development [...]

L-glutamine combined with chemotherapy produced a 44% response rate in [...]

Karyopharm Therapeutics has submitted an application to the FDA seeking [...]

Early Phase 1b data show five objective responses among six [...]

The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

Biogen’s felzartamab has been approved in China as a treatment [...]